$BKYI
BIO KEY INTERNATIONAL INC

2024 Q3 Form 10-Q Financial Statement

#000143774924026861 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $2.145M $1.141M
YoY Change 18.03% -40.83%
Cost Of Revenue $465.1K $262.3K
YoY Change -2.41% -56.73%
Gross Profit $1.680M $879.0K
YoY Change 25.3% -33.55%
Gross Profit Margin 78.31% 77.02%
Selling, General & Admin $1.608M $1.942M
YoY Change 3.91% -0.07%
% of Gross Profit 95.73% 220.91%
Research & Development $652.2K $591.2K
YoY Change 16.73% 5.92%
% of Gross Profit 38.83% 67.26%
Depreciation & Amortization $100.4K $100.2K
YoY Change 51.71% 6.17%
% of Gross Profit 5.98% 11.39%
Operating Expenses $2.260M $2.533M
YoY Change 7.31% 1.27%
Operating Profit -$580.4K -$1.654M
YoY Change -24.19% 40.35%
Interest Expense -$158.6K -$12.86K
YoY Change -447.3% -122.64%
% of Operating Profit
Other Income/Expense, Net -$158.6K -$12.86K
YoY Change -224.31% -87.31%
Pretax Income -$739.0K -$1.667M
YoY Change 15.82% 30.24%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$739.0K -$1.667M
YoY Change 15.86% 17.15%
Net Earnings / Revenue -34.45% -146.06%
Basic Earnings Per Share -$0.39 -$1.00
Diluted Earnings Per Share -$0.39 -$1.00
COMMON SHARES
Basic Shares Outstanding 1.982M 1.814M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.801M $1.260M
YoY Change 486.52% 122.87%
Cash & Equivalents $1.801M $1.260M
Short-Term Investments
Other Short-Term Assets $49.02K $28.16K
YoY Change -21.66% -62.07%
Inventory $386.9K $433.2K
Prepaid Expenses
Receivables $1.930M $904.0K
Other Receivables $49.02K $28.16K
Total Short-Term Assets $4.550M $3.015M
YoY Change -41.82% -64.67%
LONG-TERM ASSETS
Property, Plant & Equipment $162.6K $174.4K
YoY Change 134.89% 115.19%
Goodwill
YoY Change
Intangibles $1.175M $1.252M
YoY Change -22.69% -21.75%
Long-Term Investments
YoY Change
Other Assets $438.6K $348.6K
YoY Change 51.35% 21.83%
Total Long-Term Assets $1.849M $1.784M
YoY Change -4.12% -13.03%
TOTAL ASSETS
Total Short-Term Assets $4.550M $3.015M
Total Long-Term Assets $1.849M $1.784M
Total Assets $6.400M $4.799M
YoY Change -34.36% -54.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.565M $1.540M
YoY Change -5.52% -17.05%
Accrued Expenses $1.254M $1.165M
YoY Change 16.15% 29.28%
Deferred Revenue $719.8K $715.2K
YoY Change 17.92% 9.74%
Short-Term Debt $2.165M $2.010M
YoY Change -7.15% -19.55%
Long-Term Debt Due $141.9K $135.4K
YoY Change 4.83% 0.07%
Total Short-Term Liabilities $5.870M $5.575M
YoY Change -2.62% -11.18%
LONG-TERM LIABILITIES
Long-Term Debt $83.90K $114.7K
YoY Change -62.14% -55.08%
Other Long-Term Liabilities $289.8K $143.0K
YoY Change 795.7% 205.12%
Total Long-Term Liabilities $396.7K $280.6K
YoY Change -2.54% -39.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.870M $5.575M
Total Long-Term Liabilities $396.7K $280.6K
Total Liabilities $6.267M $5.855M
YoY Change -2.61% -13.1%
SHAREHOLDERS EQUITY
Retained Earnings -$127.9M -$127.2M
YoY Change 7.65% 7.6%
Common Stock $311.00 $182.00
YoY Change -67.26% -80.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $133.0K -$1.056M
YoY Change
Total Liabilities & Shareholders Equity $6.400M $4.799M
YoY Change -34.36% -54.65%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$739.0K -$1.667M
YoY Change 15.86% 17.15%
Depreciation, Depletion And Amortization $100.4K $100.2K
YoY Change 51.71% 6.17%
Cash From Operating Activities -$1.276M -$1.421M
YoY Change 688.03% 753.83%
INVESTING ACTIVITIES
Capital Expenditures $21.18K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$21.18K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.748M 1.966M
YoY Change -2147.08% -24617.46%
NET CHANGE
Cash From Operating Activities -1.276M -1.421M
Cash From Investing Activities -21.18K 0.000
Cash From Financing Activities 1.748M 1.966M
Net Change In Cash 450.8K 545.7K
YoY Change -282.3% -412.9%
FREE CASH FLOW
Cash From Operating Activities -$1.276M -$1.421M
Capital Expenditures $21.18K $0.00
Free Cash Flow -$1.297M -$1.421M
YoY Change 701.11% 753.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1815618
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1815618
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1032777
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1032777
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1928929 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4112696 usd
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1543002 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
bkyi Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
0
bkyi Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
0
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13463
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1741861
dei Entity Address Address Line1
EntityAddressAddressLine1
101 CRAWFORDS CORNER ROAD, SUITE 4116
dei Entity Address City Or Town
EntityAddressCityOrTown
HOLMDEL
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07733
dei City Area Code
CityAreaCode
732
dei Local Phone Number
LocalPhoneNumber
359-1100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BKYI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1982201
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1260351 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
511400 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
904046 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1201526 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
28164 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
99320 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
433182 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
445740 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
388786 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
364171 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
3014529 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2622157 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
174419 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
220177 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
348617 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
229806 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9341 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36905 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1252090 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1407990 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1784467 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1894878 usd
CY2024Q2 us-gaap Assets
Assets
4798996 usd
CY2023Q4 us-gaap Assets
Assets
4517035 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1539548 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1316014 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1164681 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1305848 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
715193 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
414968 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9570 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37829 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5574685 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3213389 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
142949 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
28296 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
22998 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
22998 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
114656 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
188787 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
280603 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
240081 usd
CY2024Q2 us-gaap Liabilities
Liabilities
5855288 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3453470 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
182 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
103 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
126143205 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
126047851 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15234 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22821 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127184445 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125007210 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1056292 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1063565 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4798996 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4517035 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1141286 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1928929 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3322489 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4112696 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
262272 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1606111 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
561915 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2926385 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
879014 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
322818 usd
us-gaap Gross Profit
GrossProfit
2760574 usd
us-gaap Gross Profit
GrossProfit
1186311 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1941866 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2143164 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3724839 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4074896 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
591234 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
558181 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1198755 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1248340 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2533100 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2701345 usd
us-gaap Operating Expenses
OperatingExpenses
4923594 usd
us-gaap Operating Expenses
OperatingExpenses
5323236 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1654086 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2378527 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2163020 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4136925 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
46 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
23 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
51 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
27 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-15000 usd
CY2024Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
-0 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
-0 usd
CY2024Q2 bkyi Fair Value Adjustment Of Convertible Note
FairValueAdjustmentOfConvertibleNote
-0 usd
CY2023Q2 bkyi Fair Value Adjustment Of Convertible Note
FairValueAdjustmentOfConvertibleNote
44568 usd
bkyi Fair Value Adjustment Of Convertible Note
FairValueAdjustmentOfConvertibleNote
-0 usd
bkyi Fair Value Adjustment Of Convertible Note
FairValueAdjustmentOfConvertibleNote
-97423 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8910 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
56806 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
10267 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
113725 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12864 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-101351 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14216 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31275 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1666950 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2479878 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2177236 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4168200 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
143000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
143000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1666950 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2622878 usd
us-gaap Net Income Loss
NetIncomeLoss
-2177236 usd
us-gaap Net Income Loss
NetIncomeLoss
-4311200 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1666950 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2622878 usd
us-gaap Net Income Loss
NetIncomeLoss
-2177236 usd
us-gaap Net Income Loss
NetIncomeLoss
-4311200 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
24220 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
19884 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-38530 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
92030 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1642730 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2602994 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2215766 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4219170 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.74
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1663042
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
556758
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1639183
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
556758
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1063565 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9003 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 usd
CY2024Q1 bkyi Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
1400 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-62275 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47790 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13470 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-510285 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
535728 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1939 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
456 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
48315 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
24220 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1666950 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1056292 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5301556 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12002 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
3105 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
72146 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62474 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1688322 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3756755 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16002 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
-0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
13934 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
3563 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
19884 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57831 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2622878 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1245091 usd
us-gaap Net Income Loss
NetIncomeLoss
-2177236 usd
us-gaap Net Income Loss
NetIncomeLoss
-4311200 usd
us-gaap Depreciation
Depreciation
46069 usd
us-gaap Depreciation
Depreciation
26637 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
155900 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
162166 usd
bkyi Fair Value Adjustment Of Convertible Note
FairValueAdjustmentOfConvertibleNote
0 usd
bkyi Fair Value Adjustment Of Convertible Note
FairValueAdjustmentOfConvertibleNote
-97423 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
80074 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
80717 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
1500000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
27564 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
112745 usd
bkyi Share Based Compensation Excluding Directors Fees
ShareBasedCompensationExcludingDirectorsFees
96561 usd
bkyi Share Based Compensation Excluding Directors Fees
ShareBasedCompensationExcludingDirectorsFees
120767 usd
bkyi Stock Based Fees To Directors And Consultants
StockBasedFeesToDirectorsAndConsultants
9003 usd
bkyi Stock Based Fees To Directors And Consultants
StockBasedFeesToDirectorsAndConsultants
28004 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
250000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-297480 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
757170 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-71156 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
24750 usd
bkyi Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
198885 usd
bkyi Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
75096 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12558 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-50271 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24615 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14799 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
258384 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
726657 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-141167 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-109208 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
156000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
414878 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
174437 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-51257 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-110545 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1123533 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2095192 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1869 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1869 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
2000000 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
13470 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1400 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
bkyi Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
1939 usd
bkyi Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
13934 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-77461 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-56241 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1912408 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42307 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-38055 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67490 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
748951 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2070009 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
511400 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2635522 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1260351 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
565513 usd
us-gaap Interest Paid Net
InterestPaidNet
3974 usd
us-gaap Interest Paid Net
InterestPaidNet
56919 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1141286 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3322489 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
858000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
443000 usd
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
157000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
431000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
102000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
335000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2207311 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
638956 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1005785 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
904046 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1201526 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
48771 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
77396 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
105564 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
148771 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4360526 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4373056 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
59156 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
59184 usd
CY2024Q2 bkyi Inventory Finished Goods Reserves
InventoryFinishedGoodsReserves
3986500 usd
CY2023Q4 bkyi Inventory Finished Goods Reserves
InventoryFinishedGoodsReserves
3986500 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
433182 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
445740 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
14553 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
48543 usd
us-gaap Lease Cost
LeaseCost
29106 usd
us-gaap Lease Cost
LeaseCost
111682 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9570 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37829 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y2M1D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M1D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055 pure
us-gaap Operating Lease Payments
OperatingLeasePayments
22613 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
69821 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9702 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9702 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
132 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9570 usd

Files In Submission

Name View Source Status
0001437749-24-026861-index-headers.html Edgar Link pending
0001437749-24-026861-index.html Edgar Link pending
0001437749-24-026861.txt Edgar Link pending
0001437749-24-026861-xbrl.zip Edgar Link pending
bkyi-20240630.xsd Edgar Link pending
bkyi20240630_10q.htm Edgar Link pending
ex_692358.htm Edgar Link pending
ex_692359.htm Edgar Link pending
ex_692360.htm Edgar Link pending
ex_692361.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
bkyi-20240630_cal.xml Edgar Link unprocessable
bkyi-20240630_def.xml Edgar Link unprocessable
bkyi-20240630_lab.xml Edgar Link unprocessable
bkyi-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bkyi20240630_10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending